Full Text Journal Articles by
Author Nicole G Campos

Advertisement

Find full text journal articles






Real-World HPV Vaccine Effectiveness Studies: Guideposts for Interpretation of Current and Future Studies.

Nicole G Campos, Anil K Chaturvedi, Aimée R Kreimer,

J Natl Cancer Inst (Journal of the National Cancer Institute)
[2021, 113(10):1270-1271]

Cited: 0 times

View full text PDF listing >>



Retraction: Impact and Cost-effectiveness of Human Papillomavirus Vaccination Campaigns.

Allison Portnoy, Nicole G Campos, Stephen Sy, Emily A Burger, Jamie Cohen, Catherine Regan, Jane J Kim,

Cancer Epidemiol Biomarkers Prev (Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology)
[2021, 30(6):1283]

Cited: 0 times

View full text PDF listing >>



Advertisement

Cost-Effectiveness of Offering Cervical Cancer Screening with HPV Self-Sampling among African-American Women in the Mississippi Delta.

Nicole G Campos, Isabel C Scarinci, Laura Tucker, Sylvia Peral, Yufeng Li, Mary Caroline Regan, Stephen Sy, Philip E Castle, Jane J Kim,

<h4>Background</h4>African-American women in the United States have an elevated risk of cervical cancer incidence and mortality. In the Mississippi Delta, cervical cancer disparities are particularly stark.<h4>Methods</h4>We conducted a micro-costing study alongside a group randomized trial that evaluated the efficacy of a patient-centered approach ("Choice" between self-collection at home for HPV ... Read more >>

Cancer Epidemiol Biomarkers Prev (Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology)
[2021, 30(6):1114-1121]

Cited: 0 times

View full text PDF listing >>



A proposed new generation of evidence-based microsimulation models to inform global control of cervical cancer.

Nicole G Campos, Maria Demarco, Laia Bruni, Kanan T Desai, Julia C Gage, Sally N Adebamowo, Silvia de Sanjose, Jane J Kim, Mark Schiffman,

Health decision models are the only available tools designed to consider the lifetime natural history of human papillomavirus (HPV) infection and pathogenesis of cervical cancer, and the estimated long-term impact of preventive interventions. Yet health decision modeling results are often considered a lesser form of scientific evidence due to the ... Read more >>

Prev Med (Preventive medicine)
[2021, 144:106438]

Cited: 1 time

View full text PDF listing >>



Impact of COVID-19-related care disruptions on cervical cancer screening in the United States.

Emily A Burger, Erik El Jansen, James Killen, Inge McM de Kok, Megan A Smith, Stephen Sy, Niels Dunnewind, Nicole G Campos, Jennifer S Haas, Sarah Kobrin, Aruna Kamineni, Karen Canfell, Jane J Kim,

<h4>Objectives</h4>To quantify the secondary impacts of the COVID-19 pandemic disruptions to cervical cancer screening in the United States, stratified by step in the screening process and primary test modality, on cervical cancer burden.<h4>Methods</h4>We conducted a comparative model-based analysis using three independent NCI Cancer Intervention and Surveillance Modeling Network cervical models ... Read more >>

J Med Screen (Journal of medical screening)
[2021, 28(2):213-216]

Cited: 3 times

View full text PDF listing >>



Given a choice between self-sampling at home for HPV testing and standard of care screening at the clinic, what do African American women choose? Findings from a group randomized controlled trial.

Isabel C Scarinci, Yufeng Li, Laura Tucker, Nicole G Campos, Jane J Kim, Sylvia Peral, Philip E Castle,

The goals of this study were to: (1) evaluate adherence to cervical cancer screening using a patient-centered approach that provided a choice of self-sampling at home for human papillomavirus (HPV) testing or standard of care screening at the local health department ('Choice') versus only standard of care screening at the ... Read more >>

Prev Med (Preventive medicine)
[2021, 142:106358]

Cited: 1 time

View full text PDF listing >>



Choosing the optimal HPV vaccine: The health impact and economic value of the nonavalent and bivalent HPV vaccines in 48 Gavi-eligible countries.

Emily A Burger, Allison Portnoy, Nicole G Campos, Stephen Sy, Catherine Regan, Jane J Kim,

The human papillomavirus (HPV) vaccines may provide some level of cross-protection against high-risk HPV genotypes not directly targeted by the vaccines. We evaluated the long-term health and economic impacts of routine HPV vaccination using either the nonavalent HPV vaccine or the bivalent HPV vaccine in the context of 48 Gavi-eligible ... Read more >>

Int J Cancer (International journal of cancer)
[2021, 148(4):932-940]

Cited: 3 times

View full text PDF listing >>



The cost-effectiveness of human papillomavirus self-collection among cervical cancer screening non-attenders in El Salvador.

Nicole G Campos, Karla Alfaro, Mauricio Maza, Stephen Sy, Mario Melendez, Rachel Masch, Montserrat Soler, Gabriel Conzuelo-Rodriguez, Julia C Gage, Todd A Alonzo, Philip E Castle, Juan C Felix, Miriam Cremer, Jane J Kim,

Cervical cancer screening with human papillomavirus (HPV) DNA testing has been incorporated into El Salvador's national guidelines. The feasibility of home-based HPV self-collection among women who do not attend screening at the clinic (i.e., non-attenders) has been demonstrated, but cost-effectiveness has not been evaluated. Using cost and compliance data from ... Read more >>

Prev Med (Preventive medicine)
[2020, 131:105931]

Cited: 0 times

View full text PDF listing >>



Impact and Cost-Effectiveness of Human Papillomavirus Vaccination Campaigns.

Allison Portnoy, Nicole G Campos, Stephen Sy, Emily A Burger, Jamie Cohen, Catherine Regan, Jane J Kim,

<h4>Background</h4>Data to inform evidence-based policy of human papillomavirus (HPV) vaccine delivery strategies in low- and middle-income countries are limited. We examined the cost-effectiveness of campaign compared with routine delivery strategies of adolescent female HPV vaccination in Uganda.<h4>Methods</h4>We used a multiple modeling approach that captured HPV transmission, cervical carcinogenesis, and population ... Read more >>

Cancer Epidemiol Biomarkers Prev (Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology)
[2020, 29(1):22-30]

Cited: 2 times

View full text PDF listing >>



The cost-effectiveness of implementing HPV testing for cervical cancer screening in El Salvador.

Nicole G Campos, Mauricio Maza, Karla Alfaro, Julia C Gage, Philip E Castle, Juan C Felix, Rachel Masch, Miriam Cremer, Jane J Kim,

OBJECTIVE:To assess the cost-effectiveness of HPV-based screening and management algorithms for HPV-positive women in phase 2 of the Cervical Cancer Prevention in El Salvador (CAPE) demonstration, relative to the status quo of Pap-based screening. METHODS:Data from phase 2 of the CAPE demonstration (n=8000 women) were used to inform a mathematical ... Read more >>

Int J Gynaecol Obstet (International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics)
[2019, 145(1):40-46]

Cited: 5 times

View full text PDF listing >>



Cost-Effectiveness of Cervical Cancer Screening in Women Living With HIV in South Africa: A Mathematical Modeling Study.

Nicole G Campos, Naomi Lince-Deroche, Carla J Chibwesha, Cynthia Firnhaber, Jennifer S Smith, Pam Michelow, Gesine Meyer-Rath, Lise Jamieson, Suzette Jordaan, Monisha Sharma, Catherine Regan, Stephen Sy, Gui Liu, Vivien Tsu, Jose Jeronimo, Jane J Kim,

<h4>Background</h4>Women with HIV face an increased risk of human papillomavirus (HPV) acquisition and persistence, cervical intraepithelial neoplasia, and invasive cervical cancer. Our objective was to determine the cost-effectiveness of different cervical cancer screening strategies among women with HIV in South Africa.<h4>Methods</h4>We modified a mathematical model of HPV infection and cervical ... Read more >>

J Acquir Immune Defic Syndr (Journal of acquired immune deficiency syndromes (1999))
[2018, 79(2):195-205]

Cited: 7 times

View full text PDF listing >>



Health impact of delayed implementation of cervical cancer screening programs in India: A modeling analysis.

Nicole G Campos, Vivien Tsu, Jose Jeronimo, Catherine Regan, Stephen Resch, Andrew Clark, Stephen Sy, Jane J Kim,

India has the highest burden of cervical cancer in the world. To estimate the consequences of delaying implementation of organized cervical cancer screening, we projected the avertable burden of disease under different implementation scenarios of a screening program. We used an individual-based microsimulation model of human papillomavirus (HPV) infection and ... Read more >>

Int J Cancer (International journal of cancer)
[2019, 144(4):687-696]

Cited: 1 time

View full text PDF listing >>



Health and economic benefits of single-dose HPV vaccination in a Gavi-eligible country.

Emily A Burger, Nicole G Campos, Stephen Sy, Catherine Regan, Jane J Kim,

<h4>Background</h4>Although guidelines for prophylactic human papillomavirus (HPV) vaccination recommend two doses for girls ages 9-14 years, several studies have demonstrated similar protection with one dose. Our objective was to evaluate the long-term health and economic impacts of routine one-dose HPV vaccination compared to (1) no vaccination and (2) two-dose HPV vaccination ... Read more >>

Vaccine (Vaccine)
[2018, 36(32 Pt A):4823-4829]

Cited: 10 times

View full text PDF listing >>



Community-based HPV self-collection versus visual inspection with acetic acid in Uganda: a cost-effectiveness analysis of the ASPIRE trial.

Alex K Mezei, Heather N Pedersen, Stephen Sy, Catherine Regan, Sheona M Mitchell-Foster, Josaphat Byamugisha, Musa Sekikubo, Heather Armstrong, Angeli Rawat, Joel Singer, Gina S Ogilvie, Jane J Kim, Nicole G Campos,

BACKGROUND:Cervical cancer is the leading cause of cancer death for women in Uganda, despite the potential for prevention through organised screening. Community-based self-collected human papillomavirus (HPV) testing has been proposed to reduce barriers to screening. OBJECTIVE:Our objective was to evaluate the cost-effectiveness of the Advances in Screening and Prevention of ... Read more >>

BMJ Open (BMJ open)
[2018, 8(6):e020484]

Cited: 8 times

View full text PDF listing >>



Inefficiencies of over-screening and under-screening for cervical cancer prevention in the U.S.

Philip E Castle, Cosette M Wheeler, Nicole G Campos, Stephen Sy, Emily A Burger, Jane J Kim, ,

There is limited information on the cost-inefficiencies of non-adherence to recommended cervical cancer screening or the potential value for improving non-adherence. We estimated the incremental value of adhering to recommended screening every three years with cytology, using a disease simulation model that integrated real-world screening practice data from New Mexico. ... Read more >>

Prev Med (Preventive medicine)
[2018, 111:177-179]

Cited: 1 time

View full text PDF listing >>



Cost-effectiveness of an HPV self-collection campaign in Uganda: comparing models for delivery of cervical cancer screening in a low-income setting.

Nicole G Campos, Vivien Tsu, Jose Jeronimo, Denise Njama-Meya, Mercy Mvundura, Jane J Kim,

Health Policy Plan (Health policy and planning)
[2017, 32(10):1491]

Cited: 1 time

View full text PDF listing >>



Estimating the value of point-of-care HPV testing in three low- and middle-income countries: a modeling study.

Nicole G Campos, Vivien Tsu, Jose Jeronimo, Mercy Mvundura, Jane J Kim,

<h4>Background</h4>Where resources are available, the World Health Organization recommends cervical cancer screening with human papillomavirus (HPV) DNA testing and subsequent treatment of HPV-positive women with timely cryotherapy. Newer technologies may facilitate a same-day screen-and-treat approach, but these testing systems are generally too expensive for widespread use in low-resource settings.<h4>Methods</h4>To assess ... Read more >>

BMC Cancer (BMC cancer)
[2017, 17(1):791]

Cited: 9 times

View full text PDF listing >>



Effect of Time to Diagnostic Testing for Breast, Cervical, and Colorectal Cancer Screening Abnormalities on Screening Efficacy: A Modeling Study.

Carolyn M Rutter, Jane J Kim, Reinier G S Meester, Brian L Sprague, Emily A Burger, Ann G Zauber, Mehmet Ali Ergun, Nicole G Campos, Chyke A Doubeni, Amy Trentham-Dietz, Stephen Sy, Oguzhan Alagoz, Natasha Stout, Iris Lansdorp-Vogelaar, Douglas A Corley, Anna N A Tosteson,

<b>Background:</b> Patients who receive an abnormal cancer screening result require follow-up for diagnostic testing, but the time to follow-up varies across patients and practices.<b>Methods:</b> We used a simulation study to estimate the change in lifetime screening benefits when time to follow-up for breast, cervical, and colorectal cancers was increased. Estimates ... Read more >>

Cancer Epidemiol Biomarkers Prev (Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology)
[2018, 27(2):158-164]

Cited: 11 times

View full text PDF listing >>



Cost-effectiveness of an HPV self-collection campaign in Uganda: comparing models for delivery of cervical cancer screening in a low-income setting.

Nicole G Campos, Vivien Tsu, Jose Jeronimo, Denise Njama-Meya, Mercy Mvundura, Jane J Kim,

With the availability of a low-cost HPV DNA test that can be administered by either a healthcare provider or a woman herself, programme planners require information on the costs and cost-effectiveness of implementing cervical cancer screening programmes in low-resource settings under different models of healthcare delivery. Using data from the ... Read more >>

Health Policy Plan (Health policy and planning)
[2017, 32(7):956-968]

Cited: 4 times

View full text PDF listing >>



Cost-effectiveness of HPV-based cervical cancer screening in the public health system in Nicaragua.

Nicole G Campos, Mercy Mvundura, Jose Jeronimo, Francesca Holme, Elisabeth Vodicka, Jane J Kim,

<h4>Objectives</h4>To evaluate the cost-effectiveness of human papillomavirus (HPV) DNA testing (versus Papanicolaou (Pap)-based screening) for cervical cancer screening in Nicaragua.<h4>Design</h4>A previously developed Monte Carlo simulation model of the natural history of HPV infection and cervical cancer was calibrated to epidemiological data from Nicaragua. Cost data inputs were derived using a ... Read more >>

BMJ Open (BMJ open)
[2017, 7(6):e015048]

Cited: 7 times

View full text PDF listing >>



The Cost-Effectiveness of Visual Triage of Human Papillomavirus-Positive Women in Three Low- and Middle-Income Countries.

Nicole G Campos, Jose Jeronimo, Vivien Tsu, Philip E Castle, Mercy Mvundura, Jane J Kim,

<b>Background:</b> World Health Organization guidelines support human papillomavirus (HPV) testing alone (followed by treatment with cryotherapy) or in conjunction with visual inspection with acetic acid (VIA) triage testing. Our objective was to determine the cost-effectiveness of VIA triage for HPV-positive women in low-resource settings.<b>Methods:</b> We calibrated mathematical simulation models of ... Read more >>

Cancer Epidemiol Biomarkers Prev (Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology)
[2017, 26(10):1500-1510]

Cited: 5 times

View full text PDF listing >>



The health and economic impact of scaling cervical cancer prevention in 50 low- and lower-middle-income countries.

Nicole G Campos, Monisha Sharma, Andrew Clark, Kyueun Lee, Fangli Geng, Catherine Regan, Jane Kim, Stephen Resch,

<h4>Objective</h4>To estimate the health impact, financial costs, and cost-effectiveness of scaling-up coverage of human papillomavirus (HPV) vaccination (young girls) and cervical cancer screening (women of screening age) for women in countries that will likely need donor assistance.<h4>Methods</h4>We used a model-based approach to synthesize population, demographic, and epidemiological data from 50 ... Read more >>

Int J Gynaecol Obstet (International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics)
[2017, 138 Suppl 1:47-56]

Cited: 14 times

View full text PDF listing >>



Evidence-based policy choices for efficient and equitable cervical cancer screening programs in low-resource settings.

Nicole G Campos, Vivien Tsu, Jose Jeronimo, Mercy Mvundura, Jane J Kim,

Women in developing countries disproportionately bear the burden of cervical cancer. The availability of prophylactic vaccines against human papillomavirus (HPV) types 16 and 18, which cause approximately 70% of cervical cancers, provides reason for optimism as roll-out begins with support from Gavi, the Vaccine Alliance. However, for the hundreds of ... Read more >>

Cancer Med (Cancer medicine)
[2017, 6(8):2008-2014]

Cited: 7 times

View full text PDF listing >>



Cost-effectiveness of cervical cancer screening methods in low- and middle-income countries: A systematic review.

Alex K Mezei, Heather L Armstrong, Heather N Pedersen, Nicole G Campos, Sheona M Mitchell, Musa Sekikubo, Josaphat K Byamugisha, Jane J Kim, Stirling Bryan, Gina S Ogilvie,

The incidence of cervical cancer in low- and middle-income countries (LMICs) is five times higher than that observed in high-income countries (HICs). This discrepancy is largely attributed to the implementation of cytology-based screening programmes in HICs. However, due to reduced health system infrastructure requirements, HPV testing (self- and provider-collected) and ... Read more >>

Int J Cancer (International journal of cancer)
[2017, 141(3):437-446]

Cited: 30 times

View full text PDF listing >>



To expand coverage, or increase frequency: Quantifying the tradeoffs between equity and efficiency facing cervical cancer screening programs in low-resource settings.

Nicole G Campos, Vivien Tsu, Jose Jeronimo, Mercy Mvundura, Kyueun Lee, Jane J Kim,

Cervical cancer is a leading cause of cancer death worldwide, with 85% of the disease burden residing in less developed regions. To inform evidence-based decision-making as cervical cancer screening programs are planned, implemented, and scaled in low- and middle-income countries, we used cost and test performance data from the START-UP ... Read more >>

Int J Cancer (International journal of cancer)
[2017, 140(6):1293-1305]

Cited: 7 times

View full text PDF listing >>



Advertisement


Disclaimer

0.9908 s